TRULANCE (plecanatide)
IRRITABLE BOWEL SYNDROME AGENTS·CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+1
SALIX/BAUSCH HE
Indication
Constipation predominant irritable bowel syndrome
Constipation-predominant irritable bowel syndrome (IBS-C) is a chronic disorder of gut-brain interaction affecting the gastrointestinal tract, characterized by recurrent abdominal pain linked to defecation and prolonged periods of constipation. Read more about Constipation predominant irritable bowel syndrome
26 drugs 26 manufacturers
Drugs that treat it
Common Constipation predominant irritable bowel syndrome therapies.
AMITIZA (lubiprostone)
IRRITABLE BOWEL SYNDROME AGENTS·CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
Takeda Pharmaceuticals America
LINZESS (linaclotide)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
FOREST PHARMACE
LINZESS (linaclotide)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
ACTAVIS PHARMA,
LINZESS (linaclotide)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
ACTAVIS U.S. BR
LINZESS (linaclotide)
IRRITABLE BOWEL SYNDROME AGENTS·CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+2
Allergan
TRULANCE (plecanatide)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+1
SYNERGY PHARMAC
TRULANCE (plecanatide)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME·+1
SYNERGY/BAUSCH
ZELNORM (tegaserod hydrogen maleate)
CONSTIPATION PREDOMINANT IRRITABLE BOWEL SYNDROME
US WORLDMEDS/AL
Filter & compare in the drug finder →Opens the drug finder with Constipation predominant irritable bowel syndrome preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonConstipation-predominant irritable bowel syndrome (IBS-C) is a chronic disorder of gut-brain interaction affecting the gastrointestinal tract, characterized by recurrent abdominal pain linked to defecation and prolonged periods of constipation.
Defined by standard diagnostic criteria (such as Rome IV), it is clinically distinguished by hard or lumpy stools occurring in at least 25% of bowel movements alongside loose stools occurring in fewer than 25%, frequently accompanied by abdominal bloating and straining.
The condition most commonly impacts adults, with a notable predominance in women.
Its complex pathophysiology involves delayed colonic transit, visceral hypersensitivity, dysregulated epithelial secretion, mucosal immune activation, and disrupted signaling along the bidirectional brain-gut axis.
- nih.gov
Constipation-predominant irritable bowel syndrome (IBS-C) is a chronic disorder of gut-brain interaction affecting the gastrointestinal tract, characterized by recurrent abdominal pain linked to defecation and prolonged periods of constipation
- nih.gov
Constipation-predominant irritable bowel syndrome (IBS-C) is a chronic disorder of gut-brain interaction affecting the gastrointestinal tract, characterized by recurrent abdominal pain linked to defecation and prolonged periods of constipation Its complex pathophysiology involves delayed colonic transit, visceral hypersensitivity, dysregulated epithelial secretion, mucosal immune activation, and disrupted signaling along the bidirectional brain-gut axis
- drossmancare.com
Constipation-predominant irritable bowel syndrome (IBS-C) is a chronic disorder of gut-brain interaction affecting the gastrointestinal tract, characterized by recurrent abdominal pain linked to defecation and prolonged periods of constipation
- nih.gov
Defined by standard diagnostic criteria (such as Rome IV), it is clinically distinguished by hard or lumpy stools occurring in at least 25% of bowel movements alongside loose stools occurring in fewer than 25%, frequently accompanied by abdominal bloating and straining Its complex pathophysiology involves delayed colonic transit, visceral hypersensitivity, dysregulated epithelial secretion, mucosal immune activation, and disrupted signaling along the bidirectional brain-gut axis
- pelvichealthptprep.com
Defined by standard diagnostic criteria (such as Rome IV), it is clinically distinguished by hard or lumpy stools occurring in at least 25% of bowel movements alongside loose stools occurring in fewer than 25%, frequently accompanied by abdominal bloating and straining Its complex pathophysiology involves delayed colonic transit, visceral hypersensitivity, dysregulated epithelial secretion, mucosal immune activation, and disrupted signaling along the bidirectional brain-gut axis
- gi.org
Defined by standard diagnostic criteria (such as Rome IV), it is clinically distinguished by hard or lumpy stools occurring in at least 25% of bowel movements alongside loose stools occurring in fewer than 25%, frequently accompanied by abdominal bloating and straining
- windows.net
The condition most commonly impacts adults, with a notable predominance in women
Personalize your experience
Follow Constipation predominant irritable bowel syndrome and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.